MedTrace Logo

High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis

NCT07342426 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-01-21

No results posted yet for this study

Summary

High-intensity laser therapy has gained increasing attention in recent years as a therapeutic modality. It is a non-invasive treatment that can reduce pain, increase local blood circulation, and promote tissue repair. The higher energy output of high-intensity laser therapy also have deeper tissue penetration. Several studies have investigated the effects of high-intensity laser therapy on lateral epicondylitis, and the existing literature indicates that, compared with other treatment modalities, high-intensity laser therapy is more effective in improving pain and quality of life in patients with lateral epicondylitis.

However, the dosage, duration, and treatment frequency applied in previous studies vary considerably. The therapeutic effects of high-intensity laser therapy may therefore be influenced by treatment dosage. Consequently, the purpose of this study is to compare the effects of two different dosages of high-intensity laser therapy on patients with lateral epicondylitis.

Conditions

  • Lateral Epicondylitis
  • High Intensity Laser Therapy
  • Tennis Elbow
  • High Intensity Laser

Interventions

DEVICE

High intensity laser therapy

Using high-intensity laser therapy applying on the affected area.

DEVICE

Infarred ray therapy system

Using infarred ray therapy applying on affected area for 15 minutes.

DEVICE

Transcutaneous electrical nerve stimulator

Using transcutaneous electrical nerve stimulator on the affected area fior 15 minutes.

Sponsors & Collaborators

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-12
Primary Completion
2026-02-06
Completion
2026-12-06
FDA Device
Yes

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07342426 on ClinicalTrials.gov